Two measles deaths in Pennsylvania, 2,903 cases nationwide — and a November vote on what to call it

Two people in Lancaster County, Pennsylvania died of measles. The state health department confirmed it late last month. Both were unvaccinated. One of them, according to reporting on the county coroner's review, was an infant.

They were the first measles deaths in Pennsylvania in 35 years. Which means that for three and a half decades, a Pennsylvania doctor could go an entire career without watching a patient die of this — and that is not a coincidence, it is a policy achievement, and it is the thing currently coming apart.

"Because measles was largely eliminated in the Commonwealth for more than three decades, people are not familiar with this disease and don't fully understand the potential severity of the illness," said Dr. Debra Bogen, Pennsylvania's Secretary of Health, announcing the deaths. That sentence is doing a lot of work. Unfamiliarity is not a side effect of a successful vaccine program. It is the product. And it turns out to be the product that eventually eats the program.

What is actually inside the 2,903

Big outbreak numbers get repeated without anyone opening them up, so let us open this one.

As of its August 27 count, the CDC has confirmed 2,903 measles cases in the United States this year, reported from 47 jurisdictions, plus 16 cases among international visitors. There have been 37 outbreaks, and 94% of confirmed cases — 2,737 of them — are tied to one. That last figure is the important one, and it is easy to skate past.

A country with measles under control still gets cases. Someone flies home from a place where the virus circulates, gets sick, maybe infects a household member, and it stops. The signature of control is not zero cases; it is cases that die out. When 94% of your cases belong to outbreaks, the virus is not visiting. It is finding room.

Who is getting it: 66% are children and teenagers, and 19% are under five. Of all patients this year, 94% are unvaccinated or have unknown vaccination status. Seven percent have been hospitalized, down from 11% last year.

That 7% deserves a footnote, because two different true numbers are floating around. Pennsylvania's health department, describing measles generally, says roughly 20% of cases result in hospitalization and death occurs in one to three per thousand. The CDC's 2026 tally shows 7% hospitalized. Both are real: the general figure reflects decades of measles across all settings, while a live outbreak count includes a lot of mild, quickly-identified cases in communities that are already being actively screened. The honest read is that the ratio moves and the denominator is soft. The numerator — two funerals in Lancaster County — does not move.

One bookkeeping note, because it will confuse people looking at the federal dashboard: the CDC said its weekly update would not yet include the two Pennsylvania deaths while it reviews additional information. The state has confirmed them. The federal tally, at the time of writing, has not caught up.

What "elimination status" means, and what losing it would not mean

In November, the Pan American Health Organization's Regional Verification Commission holds its annual meeting, and one item on the agenda is whether the United States still qualifies as having eliminated measles.

Decode that term, because it does not mean what it sounds like. Elimination is not the absence of measles. It is defined as the interruption of endemic measles virus transmission for more than 12 months, in the presence of high-quality surveillance. In plainer English: no single chain of the same virus lineage has been passing person-to-person on your soil, uninterrupted, for a year. The US has held that status since 2000.

The technical work behind the decision is genomic. Investigators sequence viral samples to determine whether what looks like a series of separate flare-ups is actually one lineage that never truly stopped circulating — separate importations that fizzled, or a single unbroken chain wearing different postal codes. US outbreaks in this cycle began on January 20, 2025.

The region already lost the label once. In November 2025, PAHO announced that the Americas as a region had lost measles elimination status after endemic transmission persisted for more than 12 months, driven largely by Canada. The US was categorized then as "sustained with major concerns," which is the international public health equivalent of a note home from school.

Here is what losing the designation would and would not do. It would not change what your doctor does, close a clinic, or trigger a federal program. There is no money attached. What it changes is the description: it would mean the United States has, on the technical criteria, gone back to being a country where measles circulates rather than a country where measles arrives. Practically, that means the pattern KFF describes — recurring outbreaks, school and day-care exclusions in affected communities, more hospitalizations, more strain on health departments that have already been cut.

It is a scoreboard, not a switch. But scoreboards are how countries notice they are losing.

Nine-tenths of one percent

In August the CDC published kindergarten vaccination data for the 2025-26 school year, and the headline drop was small enough to yawn at: MMR coverage went from 92.5% to 92.4%.

The yawn is the mistake. The relevant number is not the year-over-year change, it is the distance from 95% — the coverage level generally cited as necessary to stop measles from spreading through a classroom, because measles is the most contagious virus we routinely deal with and demands a higher wall than almost anything else. National coverage was 95.2% in the 2019-20 school year. Only ten states now hit 95% or better, compared with nineteen states in 2019-20.

And the trend underneath is not drifting, it is deliberate. Exemptions from one or more vaccines rose to 4.2% of kindergartners from 3.6% — roughly 155,000 children. Exemptions increased in 41 states and the District of Columbia, and 24 states now report exemption rates above 5%.

National averages also lie about measles specifically, because the virus does not meet a national average. It meets a congregation, a school district, a neighborhood. A state can post 93% and contain a community at 70%, and the community is where the outbreak happens. Lancaster County recorded 185 cases — nearly half of Pennsylvania's 393 — which is what clustering looks like when you zoom in far enough.

"I can't believe we've had two deaths in this Commonwealth from something that is completely preventable," Dr. Paul Offit of the Vaccine Education Center told CIDRAP. Dr. Andrew Racine, president of the American Academy of Pediatrics, put it as: "In 2026, decades after measles was eliminated in the United States, it is heartbreaking to witness deaths from a disease that is preventable with a vaccine."

What the shot costs — and what someone might try to charge you

This is a HealCity article, so we are going to talk about the bill, because the bill is where good intentions go to die.

Under the Affordable Care Act, most non-grandfathered health plans must cover vaccines recommended by the federal immunization advisory committee with no cost sharing — no copay, no deductible, when you use an in-network provider. For children who are uninsured, on Medicaid, or American Indian/Alaska Native, the federal Vaccines for Children program supplies the vaccine at no cost through participating providers, for anyone 18 and under. Between those two mechanisms, the overwhelming majority of American families can get MMR for zero dollars.

The gaps are specific and worth knowing. Short-term plans and travel or visitor insurance are exempt from the ACA's preventive-care requirement, and routinely exclude immunizations outright.

What that gap looks like in practice was documented by KFF Health News last year, during the West Texas outbreak. A postdoctoral researcher in Galveston brought his four-year-old in for a second measles dose. The family was on a non-ACA travel plan that excluded immunizations, and between an insurance-entry error and a hospital price list that had been updated to incorrectly high amounts, the measles-containing vaccine was billed at $1,422, plus $161 to administer it. For reference, the CDC's own program list price for that vaccine is around $278, and local pharmacies were charging $285 to $326. After a reporter called, the family ended up owing $202.75.

The vaccine was never worth $1,422. It was worth what it was worth on the day the chargemaster was wrong and nobody with leverage was in the room.

What to actually do this week

Find out what you and your kids have actually had. Not what you remember — what is written down. Most states run an immunization registry that your doctor's office, and often you, can query. Kids' records also live with the pediatrician and often with the school district.

If you are an adult and genuinely do not know. This is common and it is a real question, not a stupid one: whether you need a dose, whether a blood test for immunity makes sense, and how any of it interacts with pregnancy or a weakened immune system are all clinical calls that depend on your birth year and your history. Ask a doctor or pharmacist. Do not let an internet article — including this one — be the last word on your own dose.

Price it before you go, if you are in one of the gaps. Call your county or city health department first; many run free or low-cost immunization clinics. If you are using a pharmacy, ask for the cash price up front. If you are uninsured and your child is 18 or under, ask specifically whether the provider participates in Vaccines for Children — those are the exact four words that make the charge disappear.

Know the timeline if you are exposed. Symptoms appear 7 to 21 days after exposure, starting with fever, cough, runny nose and red watery eyes before any rash. The virus stays airborne in a room for up to two hours after an infected person has left it. If you think you have been exposed, call the office before you walk into a waiting room full of infants and cancer patients.

Thirty-five years is how long Pennsylvania went without burying anyone from this. That streak was not luck, and it did not end because the virus got smarter. In November a commission will decide what to call the situation. Lancaster County has already been told.